The scientist’s investigation covers issues in Drug, Dosage form, Cyclodextrin, Solubility and Dissolution. His work deals with themes such as MEDLINE, Bioavailability and Solubilization, which intersect with Drug. His Dosage form research incorporates themes from Biopharmaceutical, Drug delivery and Supersaturation.
His Cyclodextrin study combines topics from a wide range of disciplines, such as Combinatorial chemistry and Aqueous solution. His research in Solubility intersects with topics in Precipitation and Beta-Cyclodextrins. His studies in Dissolution integrate themes in fields like Crystallization, Loviride, Nanotechnology, Polymer and Differential scanning calorimetry.
Pharmacology, Organic chemistry, Chromatography, Dosage form and Solubility are his primary areas of study. His Organic chemistry study incorporates themes from Computational chemistry and Dexanabinol. In the field of Chromatography, his study on Cyclodextrin overlaps with subjects such as Itraconazole.
The study incorporates disciplines such as Combinatorial chemistry, Membrane, Solubilization and Aqueous solution in addition to Cyclodextrin. The concepts of his Dosage form study are interwoven with issues in Biopharmaceutical, Drug delivery, Excipient, Bioavailability and Drug. His Solubility research focuses on Micelle and how it relates to Copolymer.
His primary scientific interests are in Chromatography, Drug, Solubility, Dosage form and Pharmacology. His research in the fields of Cyclodextrin and High throughput analysis overlaps with other disciplines such as Water layer. His work carried out in the field of Cyclodextrin brings together such families of science as Combinatorial chemistry and Membrane, Permeation.
His Drug research is multidisciplinary, relying on both Bioavailability, Solubilization and Dissolution. Solubility is a primary field of his research addressed under Organic chemistry. His Nanocarriers study in the realm of Pharmacology connects with subjects such as Biochemical engineering.
Marcus E. Brewster mostly deals with Dosage form, Drug, Dissolution, Cyclodextrin and Drug delivery. His Dosage form research includes themes of Precipitation, Biopharmaceutical and Excipient. His Drug research is multidisciplinary, incorporating elements of Bioavailability, Solubilization and Solubility.
His Solubility study is related to the wider topic of Organic chemistry. His Cyclodextrin study is concerned with the larger field of Chromatography. His Inclusion compound research incorporates elements of Micelle and Aqueous solution.
This overview was generated by a machine learning system which analysed the scientist’s body of work. If you have any feedback, you can contact us here.
Pharmaceutical Applications of Cyclodextrins. 1. Drug Solubilization and Stabilization
Thorsteinn Loftsson;Marcus E. Brewster.
Journal of Pharmaceutical Sciences (1996)
Cyclodextrin-based pharmaceutics: past, present and future
Mark E. Davis;Marcus E. Brewster.
Nature Reviews Drug Discovery (2004)
Cyclodextrins as pharmaceutical solubilizers.
Marcus E. Brewster;Thorsteinn Loftsson.
Advanced Drug Delivery Reviews (2007)
Supersaturating Drug Delivery Systems: The Answer to Solubility-Limited Oral Bioavailability?
Joachim Brouwers;Marcus E Brewster;Patrick Augustijns.
Journal of Pharmaceutical Sciences (2009)
Pharmaceutical applications of cyclodextrins: basic science and product development.
Thorsteinn Loftsson;Marcus E Brewster.
Journal of Pharmacy and Pharmacology (2010)
Incorporation of drugs in an amorphous state into electrospun nanofibers composed of a water-insoluble, nonbiodegradable polymer.
Geert Verreck;Iksoo Chun;Joel Rosenblatt;Jef Peeters.
Journal of Controlled Release (2003)
Self-Association of Cyclodextrins and Cyclodextrin Complexes
Thorsteinn Loftsson;Már Másson;Marcus E. Brewster.
Journal of Pharmaceutical Sciences (2004)
Cyclodextrins as functional excipients: methods to enhance complexation efficiency.
Thorsteinn Loftsson;Marcus E. Brewster.
Journal of Pharmaceutical Sciences (2012)
Preparation and characterization of nanofibers containing amorphous drug dispersions generated by electrostatic spinning.
Geert Verreck;Iksoo Chun;Jef Peeters;Joel Rosenblatt.
Pharmaceutical Research (2003)
Characterization of the interaction of 2‐hydroxypropyl‐β‐cyclodextrin with itraconazole at pH 2, 4, and 7
Jef Peeters;Peter Neeskens;Jan P. Tollenaere;Pieter Van Remoortere.
Journal of Pharmaceutical Sciences (2002)
If you think any of the details on this page are incorrect, let us know.
We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below: